Dare Bioscience, Inc. (DARE) stock
DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.45+0.02 (+4.90%)
Close on Nov 18, 2026Market cap $6.88MP/E –Yield –
Dare Bioscience revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Dare Bioscience's revenue for the twelve months ending Jun 30, 2026 was $1.37M. For fiscal 2025 it was $1.03M, up 10429.4% from the year before. The highest annual figure on record is $10.00M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.03M | +10429.4% |
| FY2024 | Dec 31, 2024 | $9.78K | -99.7% |
| FY2023 | Dec 31, 2023 | $2.81M | -71.9% |
| FY2022 | Dec 31, 2022 | $10.00M | – |
| FY2021 | Dec 31, 2021 | $0 | -100.0% |
| FY2016 | Dec 31, 2016 | $766.00K | +857.5% |
| FY2014 | Dec 31, 2014 | $80.00K | +1233.3% |
| FY2013 | Dec 31, 2013 | $6.00K | -99.0% |
| FY2012 | Dec 31, 2012 | $625.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $187.55K | +637.6% |
| Q1 FY2026 | Mar 31, 2026 | $152.46K | +265.7% |
| Q4 FY2025 | Dec 31, 2025 | $1.02M | +4462.2% |
| Q3 FY2025 | Sep 30, 2025 | $2.26K | -75.7% |
| Q1 FY2025 | Mar 31, 2025 | $25.43K | -98.6% |
| Q3 FY2024 | Sep 30, 2024 | $41.69K | -95.8% |
| Q2 FY2024 | Jun 30, 2024 | $22.44K | – |
| Q1 FY2024 | Mar 31, 2024 | $9.30K | – |
| Q4 FY2023 | Dec 31, 2023 | $1.81M | – |
| Q3 FY2023 | Sep 30, 2023 | $1.00M | – |
| Q2 FY2023 | Jun 30, 2023 | $0 | -100.0% |
| Q1 FY2023 | Mar 31, 2023 | $0 | – |
| Q4 FY2022 | Dec 31, 2022 | $0 | – |
| Q3 FY2022 | Sep 30, 2022 | $0 | – |
| Q2 FY2022 | Jun 30, 2022 | $10.00M | +1457.6% |
| Q4 FY2021 | Dec 31, 2021 | $0 | -100.0% |
| Q3 FY2021 | Sep 30, 2021 | $0 | -100.0% |
| Q2 FY2021 | Jun 30, 2021 | $0 | – |
| Q2 FY2017 | Jun 30, 2017 | $642.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $1.19M | – |
| Q4 FY2016 | Dec 31, 2016 | $766.00K | – |
See a number that looks wrong?